Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $20,120 |
Sells | 6 | $33,607 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Nov 2022 16:31 | LUMO | LUMOS PHARMA Inc | MCCRACKEN JOSEPH S | Director | 16 Nov 2022 | Purchase | 4,000 | 5.03 | 20,120 | D |
03 Aug 2023 16:58 | LUMO | LUMOS PHARMA Inc | MCKEW JOHN C. | Chief Scientific Officer | 02 Aug 2023 | Sale | 3,407 | 3.205 | 10,919 | D |
04 Apr 2023 17:22 | LUMO | LUMOS PHARMA Inc | MCKEW JOHN C. | Chief Scientific Officer | 04 Apr 2023 | Sale | 2,214 | 3.27 | 7,240 | D |
06 Aug 2024 17:09 | LUMO | LUMOS PHARMA Inc | MCKEW JOHN C. | Chief Scientific Officer | 06 Aug 2024 | Sale | 3,407 | 1.886 | 6,426 | D |
03 Apr 2024 17:10 | LUMO | LUMOS PHARMA Inc | MCKEW JOHN C. | Chief Scientific Officer | 03 Apr 2024 | Sale | 2,214 | 2.775 | 6,144 | D |
03 Feb 2023 17:03 | LUMO | LUMOS PHARMA Inc | MCKEW JOHN C. | Chief Scientific Officer | 02 Feb 2023 | Sale | 439 | 3.53 | 1,550 | D |
07 Feb 2024 17:22 | LUMO | LUMOS PHARMA Inc | MCKEW JOHN C. | Chief Scientific Officer | 06 Feb 2024 | Sale | 438 | 3.032 | 1,328 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)